B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 7305-7313

  Foerster, Christian ^a   Voelxen, Nadine ^a   Rakhmanov, Mirzokhid ^a   Keller, Baerbel ^a   Gutenberger, Sylvia ^a   Goldacker, Sigune ^a   Thiel, Jens ^a   Feske, Stefan ^b   Peter, Hans Hartmut ^a   Warnatz, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; CD22 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; PHOSPHOLIPASE C GAMMA2; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; ATTENUATION; B LYMPHOCYTE; CALCIUM SIGNALING; CALCIUM TRANSPORT; COMMON VARIABLE IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY TYPE 1A; CONTROLLED STUDY; DISEASE CLASSIFICATION; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CALCIUM SIGNALING; CELL SEPARATION; COMMON VARIABLE IMMUNODEFICIENCY; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, B-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77953627375     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000434     Document Type: Article

References (49)

1. Notarangelo, L. D., A. Fischer, R. S. Geha, J. L. Casanova, H. Chapel, M. E. Conley, C. Cunningham-Rundles, A. Etzioni, L. Hammartröm, S. Nonoyama, et al; International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies. 2009. Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 124: 1161-1178.
2. Bacchelli, C., S. Buckridge, A. J. Thrasher, and H. B. Gaspar. 2007. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin. Exp. Immunol. 149: 401-409.
3. Kralovicova, J., L. Hammarström, A. Plebani, A. D. Webster, and I. Vorechovsky. 2003. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170: 2765-2775. (Pubitemid 36245672)
4. Warnatz, K., A. Denz, R. Dräger, M. Braun, C. Groth, G. Wolff-Vorbeck, H. Eibel, M. Schlesier, and H. H. Peter. 2002. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99: 1544-1551.
5. Piqueras, B., C. Lavenu-Bombled, L. Galicier, F. Bergeron-van der Cruyssen, L. Mouthon, S. Chevret, P. Debré, C. Schmitt, and E. Oksenhendler. 2003. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23: 385-400.
6. Wehr, C., T. Kivioja, C. Schmitt, B. Ferry, T. Witte, E. Eren, M. Vlkova, M. Hernandez, D. Detkova, P. R. Bos, et al. 2008. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111: 77-85.
7. Groth, C., R. Drager, K. Warnatz, G. Wolff-Vorbeck, S. Schmidt, H. Eibel, M. Schlesier, and H. H. Peter. 2002. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin. Exp. Immunol. 129: 133-139.
8. Denz, A., H. Eibel, H. Illges, G. Kienzle, M. Schlesier, and H. H. Peter. 2000. Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients. Eur. J. Immunol. 30: 1069-1077.
9. Bryant, A., N. C. Calver, E. Toubi, A. D. Webster, and J. Farrant. 1990. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin. Immunol. Immunopathol. 56: 239-248.
10. Dolmetsch, R. E., R. S. Lewis, C. C. Goodnow, and J. I. Healy. 1997. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386: 855-858.
11. Kurosaki, T., and M. Hikida. 2009. Tyrosine kinases and their substrates in B lymphocytes. Immunol. Rev. 228: 132-148.
12. Oh-hora, M., and A. Rao. 2008. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 20: 250-258.
13. Feske, S. 2007. Calcium signaling in lymphocyte activation and disease. Nat. Rev. Immunol. 7: 690-702.
14. Rhee, S. G., and Y. S. Bae. 1997. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272: 15045-15048.
15. Hashimoto, A., K. Takeda, M. Inaba, M. Sekimata, T. Kaisho, S. Ikehara, Y. Homma, S. Akira, and T. Kurosaki. 2000. Cutting edge: essential role of phospholipase C-gamma 2 in B cell development and function. J. Immunol. 165: 1738-1742. (Pubitemid 30643122)
16. Hikida, M., S. Johmura, A. Hashimoto, M. Takezaki, and T. Kurosaki. 2003. Coupling between B cell receptor and phospholipase C-gamma2 is essential for mature B cell development. J. Exp. Med. 198: 581-589.
17. Wang, D., J. Feng, R. Wen, J. C. Marine, M. Y. Sangster, E. Parganas, A. Hoffmeyer, C. W. Jackson, J. L. Cleveland, P. J. Murray, and J. N. Ihle. 2000. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 13: 25-35.
18. Hikida, M., S. Casola, N. Takahashi, T. Kaji, T. Takemori, K. Rajewsky, and T. Kurosaki. 2009. PLC-gamma2 is essential for formation and maintenance of memory B cells. J. Exp. Med. 206: 681-689.
19. van Zelm, M. C., I. Reisli, M. van der Burg, D. Castaño, C. J. van Noesel, M. J. van Tol, C. Woellner, B. Grimbacher, P. J. Patiño, J. J. van Dongen, and J. L. Franco. 2006. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354: 1901-1912.
20. Fluckiger, A. C., Z. Li, R. M. Kato, M. I. Wahl, H. D. Ochs, R. Longnecker, J. P. Kinet, O. N. Witte, A. M. Scharenberg, and D. J. Rawlings. 1998. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J. 17: 1973-1985.
21. Simon, H. U., G. B. Mills, S. Hashimoto, and K. A. Siminovitch. 1992. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J. Clin. Invest. 90: 1396-1405.
22. Warnatz, K., C. Wehr, R. Dräger, S. Schmidt, H. Eibel, M. Schlesier, and H. H. Peter. 2002. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 206: 502-513.
23. Nitschke, L. 2009. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol. Rev. 230: 128-143.
24. Nitschke, L. 2005. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr. Opin. Immunol. 17: 290-297.
25. Rakhmanov, M., B. Keller, S. Gutenberger, C. Foerster, M. Hoenig, G. Driessen, M. van der Burg, J. J. van Dongen, E. Wiech, M. Visentini, et al. 2009. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl. Acad. Sci. USA 106: 13451-13456.
26. Glynne, R., G. Ghandour, J. Rayner, D. H. Mack, and C. C. Goodnow. 2000. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176: 216-246.
27. Krzysiek, R., E. A. Lefèvre, W. Zou, A. Foussat, J. Bernard, A. Portier, P. Galanaud, and Y. Richard. 1999. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. J. Immunol. 162: 4455-4463. (Pubitemid 29314842)
28. Glynne, R., S. Akkaraju, J. I. Healy, J. Rayner, C. C. Goodnow, and D. H. Mack. 2000. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 403: 672-676.
29. Engelke, M., N. Engels, K. Dittmann, B. Stork, and J. Wienands. 2007. Ca(2+) signaling in antigen receptor-activated B lymphocytes. Immunol. Rev. 218: 235-246.
30. Antony, P., K. Hoek, B. Sarmah, and W. N. Khan. 2007. Micro-scale flow cytometry-based and biochemical analysis of lipid signaling in primary B cell subpopulations. Biol. Proced. Online 9: 73-83.
31. Fujimoto, M., J. C. Poe, M. Hasegawa, and T. F. Tedder. 2001. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation. J. Biol. Chem. 276: 44820-44827.
32. Scharenberg, A. M., L. A. Humphries, and D. J. Rawlings. 2007. Calcium signalling and cell-fate choice in B cells. Nat. Rev. Immunol. 7: 778-789.
33. Feske, S., Y. Gwack, M. Prakriya, S. Srikanth, S. H. Puppel, B. Tanasa, P. G. Hogan, R. S. Lewis, M. Daly, and A. Rao. 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185.
34. Feske, S., J. Giltnane, R. Dolmetsch, L. M. Staudt, and A. Rao. 2001. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2: 316-324.
35. McCarl, C. A., C. Picard, S. Khalil, T. Kawasaki, J. Rother, A. Papolos, J. Kutok, C. Hivroz, F. Ledeist, K. Plogmann, S. Ehl, G. Notheis, M. H. Albert, B. H. Belohradsky, J. Kirschner, A. Rao, A. Fischer, and S. Feske. 2009. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J. Allergy Clin. Immunol. 124: 1311-1318.e7.
36. Gwack, Y., S. Srikanth, M. Oh-Hora, P. G. Hogan, E. D. Lamperti, M. Yamashita, C. Gelinas, D. S. Neems, Y. Sasaki, S. Feske, et al. 2008. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol. Cell. Biol. 28: 5209-5222.
37. Oh-Hora, M., M. Yamashita, P. G. Hogan, S. Sharma, E. Lamperti, W. Chung, M. Prakriya, S. Feske, and A. Rao. 2008. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat. Immunol. 9: 432-443.
38. Beyersdorf, N., A. Braun, T. Vögtle, D. Varga-Szabo, R. R. Galdos, S. Kissler, T. Kerkau, and B. Nieswandt. 2009. STIM1-independent T cell development and effector function in vivo. J. Immunol. 182: 3390-3397.
39. Feske, S. 2009. ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond. Immunol. Rev. 231: 189-209.
40. Gross, A. J., J. R. Lyandres, A. K. Panigrahi, E. T. Prak, and A. L. DeFranco. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182: 5382-5392.
41. Stork, B., M. Engelke, J. Frey, V. Horejsí, A. Hamm-Baarke, B. Schraven, T. Kurosaki, and J. Wienands. 2004. Grb2 and the non-T cell activation linker NTAL constitute a Ca(2+)-regulating signal circuit in B lymphocytes. Immunity 21: 681-691. (Pubitemid 39487891)
42. Sato, S., P. J. Jansen, and T. F. Tedder. 1997. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc. Natl. Acad. Sci. USA 94: 13158-13162.
43. Nitschke, L., R. Carsetti, B. Ocker, G. Köhler, and M. C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7: 133-143.
44. Poe, J. C., M. Fujimoto, P. J. Jansen, A. S. Miller, and T. F. Tedder. 2000. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J. Biol. Chem. 275: 17420-17427.
45. Chen, J., P. A. McLean, B. G. Neel, G. Okunade, G. E. Shull, and H. H. Wortis. 2004. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat. Immunol. 5: 651-657.
46. Nolz, J. C., T. S. Gomez, P. Zhu, S. Li, R. B. Medeiros, Y. Shimizu, J. K. Burkhardt, B. D. Freedman, and D. D. Billadeau. 2006. The WAVE2 complex regulates actin cytoskeletal reorganization and CRAC-mediated calcium entry during T cell activation. Curr. Biol. 16: 24-34.
47. Park, J. Y., A. Shcherbina, F. S. Rosen, A. P. Prodeus, and E. Remold-O'Donnell. 2005. Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin. Exp. Immunol. 139: 297-305.
48. Healy, J. I., R. E. Dolmetsch, L. A. Timmerman, J. G. Cyster, M. L. Thomas, G. R. Crabtree, R. S. Lewis, and C. C. Goodnow. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6: 419-428.
49. Picard, C., C. A. McCarl, A. Papolos, S. Khalil, K. Lüthy, C. Hivroz, F. LeDeist, F. Rieux-Laucat, G. Rechavi, A. Rao, et al. 2009. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N. Engl. J. Med. 360: 1971-1980.